Evidence map›Paper›PMID 38251194›Full record

ArticleNursing reports (Pavia, Italy)2024

Hematopoietic Stem Cell Transplantation Impact on Patients' Perceived Quality of Life: A Longitudinal Study.

Pablo Ortolá-Alonso, Enric Santacatalina-Roig, Elena Chover-Sierra, Antoni Merelles-Tormo, María Luisa Ballestar-Tarín, Antonio Martínez-Sabater

Open access · goldAbstract read
In one paragraph

Article in Nursing reports (Pavia, Italy), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pablo Ortolá-AlonsoNursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.
Enric Santacatalina-RoigNursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.
Elena Chover-SierraNursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.ORCID 0000-0002-4141-6956
Antoni Merelles-TormoNursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.ORCID 0000-0001-8741-1926
María Luisa Ballestar-TarínNursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.ORCID 0000-0003-3998-2956
Antonio Martínez-SabaterNursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.ORCID 0000-0002-6440-1431
Universitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this paper was to evaluate the quality of life of adult patients with onco-hematological disease treated with hematopoietic stem cell transplantation up to two years post-transplantation.

methodA quantitative, observational, longitudinal, and analytical study was conducted with 121 participants diagnosed with onco-hematological cancer who underwent hematopoietic stem cell transplantation between October 2017 and September 2019, with a 2-year post-transplantation follow-up, of whom only 39 completed the study. The Functional Assessment of Cancer Therapy-Bone Marrow Transplantation (FACT-BMT) questionnaire and its subscales, Functional Assessment of Cancer Therapy-General (FACT-BMT) and Functional Assessment of Cancer Therapy Trial Outcome Index (FACT-TOI), developed by the Functional Assessment of Chronic Illness Therapy (FACIT) and validated for Spain, were used to assess quality of life.

resultThe average age for hematopoietic stem cell transplantation was 54 years, with a majority of male participants. The evaluation of quality of life showed a decrease at the time of hospital discharge, followed by a progressive improvement up to one year after the transplantation. There was a significant difference in the quality of life questionnaire scores between both sexes during all stages of the research, with higher scores in male participants. The length of hospital stay significantly affected patients' physical and functional well-being, and marital status was related to differences in the perception of quality of life.

conclusionsDespite the initial decrease in quality of life for patients undergoing hematopoietic stem cell transplantation, levels of quality of life similar to baseline are regained one year after the transplantation. Sociodemographic variables are related to how these patients perceive their quality of life. However, further studies with a larger sample size are needed for more precise results.

Indexed as

cancerhematopoietic stem cell transplantationnursingoncologyquality of life

Identifiers

PMID38251194
PMCPMC10801518
OpenAlexW4391025990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.